⚠️ NOT FOR HUMAN CONSUMPTION – FOR RESEARCH PURPOSES ONLY ⚠️ CerebrolysinA proprietary, multimodal neuropeptide preparation derived from enzymatically processed porcine brain tissue, containing a complex mixture of low molecular weight peptides and free amino acids. Researched for its neurotrophic and neuroprotective properties in models of central nervous system injuries and neurodegeneration. Form: Aqueous lyophilized formulation Purity: >98% (HPLC, based on peptide content) Storage: Store in a cool, dry, and dark environment; long-term storage typically at –20 °C(Sources: ScienceDirect overview, MDPI psychiatry review) Research Highlights Comprised of approximately 25% low molecular weight peptides and 75% free amino acids, along with trace microelements such as magnesium, potassium, calcium, selenium, and zinc (Source: MDPI psychiatry review). Contains a variety of neuropeptide fragments—including NGF, BDNF, CNTF, enkephalins, orexin, and peptide fragments such as P-21—suggested to mimic endogenous neurotrophic factors and support neural repair (Source: Professional Monograph PDF). Demonstrated neurotrophic efficacy in preclinical bioassays (e.g., EGFP‑NF‑L expression in PC12 cells), whereas preparations marketed as “similar” showed markedly different peptide profiles and lacked comparable neuroactivity (Source: Comparative bioactivity study). Investigated for potential benefits in CNS-related models including stroke, traumatic brain injury, dementia, and psychiatric conditions; proposed mechanisms include neurogenesis, synaptic plasticity, and modulation of neuroinflammatory pathways (Sources: ScienceDirect overview, MDPI psychiatry review). This compound is strictly intended for laboratory research use only.It is not approved for human or veterinary use, not a dietary supplement, and must not be used to diagnose, treat, cure, or prevent any disease or condition. FOR LABORATORY USE ONLY. NOT FOR HUMAN CONSUMPTION.